Recent advances in combined modality therapy for locally advanced head and neck cancer

Current Cancer Drug Targets

Volumn 7, Issue 7, 2007, Pages 674-680

  Wirth, Lori J ^a,b   Posner, Marshall R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Chemoradiotherapy; Sequential therapy; Squamous cell carcinoma of the head and neck

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN; DOCETAXEL; FLUOROURACIL; HYDROXYUREA; PACLITAXEL;

ADVANCED CANCER; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL TRIAL; DEATH; DISEASE FREE SURVIVAL; HEAD AND NECK CANCER; HEART INFARCTION; HUMAN; HYPOPHARYNX CANCER; INTENSITY MODULATED RADIATION THERAPY; LARYNGECTOMY; LARYNX CANCER; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; ORGAN PRESERVATION; OROPHARYNX CANCER; PROGNOSIS; REVIEW; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; TREATMENT INDICATION; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS;

EID: 35948978512     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800907782418329     Document Type: Review

References (49)

1. Hoffman, H. T.; Karnell, L. H.; Funk, G. F.; Robinson, R. A.; Menck, H. R. The National Cancer Data Base report on cancer of the head and neck. Arch. Otolaryngol. Head Neck Surg. 1998, 124(9), 951-962.
2. Edwards, B. K.; Brown, M. L.; Wingo, P.A.; Howe, H. L.; Ward, E.; Ries, L. A.; Schrag, D.; Jamison, P. M.; Jemal, A.; Wu, X. C.; Friedman, C.; Harlan, L.; Warren, J.; Anderson, R. N.; Pickle, L. W. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J. Natl. Cancer Inst. 2005, 97(19), 1407-1427.
3. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N. Engl. J. Med. 1991, 324(24), 1685-1690.
4. Lefebvre, J. L.; Chevalier, D.; Luboinski, B.; Kirkpatrick, A.; Collette, L.; Sahmoud, T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J. Natl. Cancer Inst. 1996, 88(13), 890-899.
5. Brizel, D. M.; Albers, M. E.; Fisher, S. R.; Scher, R. L.; Richtsmeier, W. J.; Hars, V.; George, S. L.; Huang, A. T.; Prosnitz, L. R. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N. Engl. J. Med. 1998, 338(25), 1798-1804.
6. Wendt, T. G.; Grabenbauer, G. G.; Rodel, C. M.; Thiel, H. J.; Aydin, H.; Rohloff, R.; Wustrow, T. P.; Iro, H.; Popella, C.; Schalhorn, A. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J. Clin. Oncol. 1998, 16(4), 1318-1324.
7. Calais, G.; Alfonsi, M.; Bardet, E.; Sire, C.; Germain, T.; Bergerot, P.; Rhein, B.; Tortochaux, J.; Oudinot, P.; Bertrand, P. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J. Natl. Cancer Inst. 1999, 91(24), 2081-2086.
8. Jeremic, B.; Shibamoto, Y.; Milicic, B.; Nikolic, N.; Dagovic, A.; Aleksandrovic, J.; Vaskovic, Z.; Tadic, L. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J. Clin. Oncol. 2000, 18(7), 1458-1464.
9. Staar, S.; Rudat, V.; Stuetzer, H.; Dietz, A.; Volling, P.; Schroeder, M.; Flentje, M.; Eckel, H. E.; Mueller, R. P. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy - results of a multicentric randomized German trial in advanced head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 2001, 50(5), 1161-1171.
10. Forastiere, A. A.; Goepfert, H.; Maor, M.; Pajak, T. F.; Weber, R.; Morrison, W.; Glisson, B.; Trotti, A.; Ridge, J. A.; Chao, C.; Peters, G.; Lee, D. J.; Leaf, A.; Ensley, J.; Cooper, J. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N. Engl. J. Med. 2003, 349(22), 2091-2098.
11. Denis, F.; Garaud, P.; Bardet, E.; Alfonsi, M.; Sire, C.; Germain, T.; Bergerot, P.; Rhein, B.; Tortochaux, J.; Calais, G. Final results of the 94-01 French head and neck oncology and radiotherapy group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J. Clin. Oncol. 2004, 22(1), 69-76.
12. Fountzilas, G.; Ciuleanu, E.; Dafni, U.; Plataniotis, G.; Kalogera-Fountzila, A.; Samantas, E.; Athanassiou, E.; Tzitzikas, J.; Ciuleanu, T.; Nikolaou, A.; Pantelakos, P.; Zaraboukas, T.; Zamboglou, N.; Daniilidis, J.; Ghilezan, N. Concomitant radiochemotherapy vs radiotherapy alone in patients with head and neck cancer: a Hellenic Cooperative Oncology Group Phase III Study. Med. Oncol. 2004, 21(2), 95-107.
13. Huguenin, P.; Beer, K. T.; Allal, A.; Rufibach, K.; Friedli, C.; Davis, J. B.; Pestalozzi, B.; Schmid, S.; Thoni, A.; Ozsahin, M.; Bernier, J.; Topfer, M.; Kann, R.; Meier, U. R.; Thum, P.; Bieri, S.; Notter, M.; Lombriser, N.; Glanzmann, C. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy. J. Clin. Oncol. 2004, 22(23), 4665-4673.
14. Semrau, R.; Mueller, R. P.; Stuetzer, H.; Staar, S.; Schroeder, U.; Guntinas-Lichius, O.; Kocher, M.; Eich, H. T.; Dietz, A.; Flentje, M.; Rudat, V.; Volling, P.; Schroeder, M.; Eckel, H. E. Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: updated results of a randomized multicentric trial in advanced head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 2006, 64(5), 1308-1316.
15. Pignon, J. P.; Bourhis, J.; Domenge, C.; Designe, L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000, 355(9208), 949-955.
16. Rooney, M.; Kish, J.; Jacobs, J.; Kinzie, J.; Weaver, A.; Crissman, J.; Al-Sarraf, M. Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin. Cancer 1985, 55(5), 1123-1128.
17. Ensley, J. F.; Jacobs, J. R.; Weaver, A.; Kinzie, J.; Crissman, J.; Kish, J. A.; Cummings, G.; Al-Sarraf, M. Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck. Cancer 1984, 54(5), 811-814.
18. Kies, M. S.; Gordon, L. I.; Hauck, W. W.; Krespi, Y.; Ossoff, R. H.; Pecaro, B. C.; Yuska, C.; Lamut, C. H.; Brand, W. N.; Chang, S. K.; Becker, S.P. Analysis of complete responders after initial treatment with chemotherapy in head and neck cancer. Otolaryngol. Head Neck Surg. 1985, 93(2), 199-205.
19. Forastiere, A. A.; Maor, M.; Weber, R. S.; Pajak, T.; Glisson, B.; Trotti, A.; Ridge, J.; Ensley, J.; Chao, C.; Cooper, J. Long-term result of Intergroup RTOG 91-11: A phase III trial to preserve the larynx-Induction cisplatin/5FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy. Proc. Am. Soc. Clin. Oncol. 2006, 24, 5517.
20. Guadagnolo, B. A.; Haddad, R. I.; Posner, M. R.; Weeks, L.; Wirth, L. J.; Norris, C. M.; Sullivan, C. A.; Goguen, L.; Busse, P. M.; Tishler, R. Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer. Am. J. Clin. Oncol. 2005, 28(4), 371-378.
21. Urba, S.; Wolf, G.; Eisbruch, A.; Worden, F.; Lee, J.; Bradford, C.; Teknos, T.; Chepeha, D.; Prince, M.; Hogikyan, N.; Taylor, J. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for Combined Chemoradiation: A New Treatment Paradigm. J. Clin. Oncol. 2006, 24(4), 593-598.
22. Calais, G.; Pointreau, Y.; Alfonsi, M.; Sire, C.; Tuchais, C.; Tortochaux, J.; Bourhis, J.; Guerrif, S.; Garaud, P. Randomized Phase III trial comparing induction chemotherapy using cisplatinum, fluorouracil with or without docetaxel for organ preservation in hypopharynx and larynx cancer. Preliminary results of GORTEC 2000-01. Proc. Am. Soc. Clin. Oncol. 2006, 24, 5506.
23. Adelstein, D. J.; Li, Y.; Adams, G. L.; Wagner, H. Jr.; Kish, J. A.; Ensley, J. F.; Schuller, D. E.; Forastiere, A. A. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J. Clin. Oncol. 2003, 21(1), 92-98.
24. Suntharalingam, M.; Haas, M. L.; Conley, B. A.; Egorin, M. J.; Levy, S.; Sivasailam, S.; Herman, J. M.; Jacobs, M. C.; Gray, W. C.; Ord, R. A.; Aisner, J. A.; Van Echo, D. A. The use of carboplatinum and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 2000, 47(1), 49-56.
25. Garden, A. S.; Harris, J.; Vokes, E. E.; Forastiere, A. A.; Ridge, J. A.; Jones, C.; Horwitz, E. M.; Glisson, B. S.; Nabell, L.; Cooper, J. S.; Demas, W.; Gore, E. Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase II trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. J. Clin. Oncol. 2004, 22(14), 2856-2864.
26. Horiot, J. C.; Le Fur, R.; N'Guyen, T.; Chenal, C.; Schraub, S.; Alfonsi, S.; Gardani, G.; Van Den Bogaert, W.; Danczak, S.; Bolla, M.; Van Glabbeke, M.; DePauw, M. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother. Oncol. 1992, 25(4), 231-241.
27. Fu, K. K.; Pajak, T. F.; Trotti, A.; Jones, C. U.; Spencer, S. A.; Phillips, T. L.; Garden, A. S.; Ridge, J. A.; Cooper, J. S.; Ang, K. K. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int. J. Radiat. Oncol. Biol. Phys. 2000, 48(1), 7-16.
28. Overgaard, J.; Hansen, H. S.; Specht, L.; Overgaard, M.; Grau, C.; Andersen, E.; Bentzen, J.; Bastholt, L.; Hansen, O.; Johansen, J.;Andersen, L.; Evensen, J. F. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 2003, 362(9388), 933-940.
29. Budach, V.; Stuschke, M.; Budach, W.; Baumann, M.; Geismar, D.; Grabenbauer, G.; Lammert, I.; Jahnke, K.; Stueben, G.; Herrmann, T.; Bamberg, M.; Wust, P.; Hinkelbein, W.; Wernecke, K. D. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial. J. Clin. Oncol. 2005, 23(6), 1125-1135.
30. Barendsen, G. W. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int. J. Radiat. Oncol. Biol. Phys. 1982, 8(11), 1981-1997.
31. Thames, H. D. Jr.; Withers, H. R.; Peters, L. J.; Fletcher, G. H. Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships. Int. J. Radiat. Oncol. Biol. Phys. 1982, 8(2), 219-226.
32. Ang, K. K.; Harris, J.; Garden, A. S.; Trotti, A.; Jones, C. U.; Carrascosa, L.; Cheng, J. D.; Spencer, S. S.; Forastiere, A.; Weber, R. S. Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99-14. J. Clin. Oncol. 2005, 23(13), 3008-3015.
33. Mendenhall, W. M.; Amdur, R. J.; Palta, J. R. Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls. J. Clin. Oncol. 2006, 24(17), 2618-2623.
34. Chao, K. S.; Ozyigit, G.; Tran, B. N.; Cengiz, M.; Dempsey, J. F.; Low, D. A. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 2003, 55(2), 312-321.
35. Chao, K. S.; Ozyigit, G.; Blanco, A. I.; Thorstad, W. L.; Deasy, J. O.; Haughey, B. H.; Spector, G. J.; Sessions, D. G. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume. Int. J. Radiat. Oncol. Biol. Phys. 2004, 59(1), 43-50.
36. Eisbruch, A.; Marsh, L. H.; Dawson, L. A.; Bradford, C. R.; Teknos, T. N.; Chepeha, D. B.; Worden, F. P.; Urba, S.; Lin, A.; Schipper, M. J.; Wolf, G. T. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int. J. Radiat. Oncol. Biol. Phys. 2004, 59(1), 28-42.
37. Rosenthal, D. I.; Lewin, J. S.; Eisbruch, A. Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. J. Clin. Oncol. 2006, 24(17), 2636-2643.
38. Bonner, J. A.; Harari, P. M.; Giralt, J.; Azarnia, N.; Shin, D. M.; Cohen, R. B.; Jones, C. U.; Sur, R.; Raben, D.; Jassem, J.; Ove, R.; Kies, M. S.; Baselga, J.; Youssoufian, H.; Amellal, N.; Rowinsky, E. K.; Ang, K. K. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 2006, 354(6), 567-578.
39. Pfister, D. G.; Su, Y. B.; Kraus, D. H.; Wolden, S. L.; Lis, E.; Aliff, T. B.; Zahalsky, A. J.; Lake, S.; Needle, M. N.; Shaha, A. R.; Shah, J. P.; Zelefsky, M. J. Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm. J. Clin. Oncol. 2006, 24(7), 1072-1078.
40. Domenge, C.; Hill, C.; Lefebvre, J. L.; De Raucourt, D.; Rhein, B.; Wibault, P.; Marandas, P.; Coche-Dequeant, B.; Stromboni-Luboinski, M.; Sancho-Garnier, H.; Luboinski, B. Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. Br. J. Cancer 2000, 83(12), 1594-1598.
41. Depondt, J.; Gehanno, P.; Martin, M.; Lelievre, G.; Guerrier, B.; Peytral, C.; Schott, H.; Pellae-Cosset, B. Neoadjuvant chemotherapy with carboplatin/5-fluorouracil in head and neck cancer. Oncology 1993, 50 (Suppl 2), 23-27.
42. Paccagnella, A.; Orlando, A.; Marchiori, C.; Zorat, P. L.; Cavaniglia, G.; Sileni, V. C.; Jirillo, A.; Tomio, L.; Fila, G.; Fede, A.; Endrizzi, L.; Bari, M.; Sampognaro, E.; Balli, M.; Gava, A.; Pappagallo, G. L.; Fiorention M. V. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: A study by the Gruppo di Studio sui Tumori della Testa e del collo. Journal of the National Cancer Institute 1994, 86, 265-272.
43. Hitt, R.; Lopez-Pousa, A.; Martinez-Trufero, J.; Escrig, V.; Carles, J.; Rizo, A.; Isla, D.; Vega, M. E.; Marti, J. L.; Lobo, F.; Pastor, P.; Valenti, V.; Belon, J. ; Sanchez, M. A.; Chaib, C.; Pallares, C.; Anton, A.; Cervantes, A.; Paz-Ares, L.; Cortes-Funes, H. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J. Clin. Oncol. 2005, 23(34), 8636-8645.
44. Vermorken, J. B.; Remenar, E.; Van Herpen, C.; Germa Lluch, J.; Stewart, S.; Gorlia, T.; Degardin, M.; Schollen, K.; Bernier, J. Standard cisplatin/infusional 5-fluorouracil (PF) vs docetaxel (T) plus PF (TPF) as neoadjuvant chemotherapy for nonresectable locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN): A phase III trial of the EORTC Head and Neck Cancer Group (EORTC #24971). Proc. Am. Soc. Clin. Oncol. 2004, 22, 5508.
45. Posner, M.; Hershock, D.; Le Lann, L.; Devlin, P.; Haddad, R. A Phase III multicenter trial of docetaxel cisplatin and 5-fluorouracil versus cisplatin plus 5-fluorouracil induction chemotherapy followed by chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck. Proc. Am. Soc. Clin. Oncol. 2006, Special Scientific Session.
46. Norton, L.; Simon, R.; Brereton, H. D.; Bogden, A. E. Predicting the course of Gompertzian growth. Nature 1976, 264(5586), 542-545.
47. Norton, L. Conceptual and practical implications of breast tissue geometry: toward a more effective, less toxic therapy. Oncologist 2005, 10(6), 370-381.
48. Hitt, R.; Grau, J.; Lopez-Pousa, A.; Berrocal, A.; García-Giron, C.; Belon, J.; Sastre, J.; Martinez-Trufero, J.; Cortés-Funes, H.; Cruz-Hernandez, J. Randomized Phase II/III clinical trial of induction chemotherapy with either cisplatin/5-fluorouracil or docetaxel/cisplatin/5- fluorouracil followed by chemoradiotherapy vs CRT alone for patients with unresectable locally advanced head and neck cancer. Proc. Am. Soc. Clin. Oncol. 2006, 24, 5515.
49. Paccagnella, A.; Buffoli, A.; Koussis, H.; D'Amanzo, P.; Loreggian, L.; Bonetti, A.; Valduga, F.; Gava, A.; Ardizzoia, A.; Sguotti, C. Randomized Phase II trial of concomitant CT/RT versus TPF followed by concomitant CT/RT in locally advanced squamous cell carcinoma of the head and neck. Proc. Am. Soc. Clin. Oncol. 2006, 24, 5518.